The clinical potential of adipogenesis and obesity-related microRNAs

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 28, Issue 2, 2018, Pages 91-111

  Zaiou, M ^a   El Amri, H ^b   Bakillah, A ^c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Institut de Criminalistique de la Gendarmerie Royale   (Morocco)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Adipogenesis; Biomarkers; Metabolic disease; microRNAs; Obesity; Type 2 diabetes mellitus

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 125; MICRORNA 133; MICRORNA 140; MICRORNA 142; MICRORNA 143; MICRORNA 155; MICRORNA 17; MICRORNA 193B; MICRORNA 196A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 2355; MICRORNA 26; MICRORNA 27; MICRORNA 27A; MICRORNA 27B; MICRORNA 30; MICRORNA 31; MICRORNA 32; MICRORNA 328; MICRORNA 33; MICRORNA 34A; MICRORNA 365; MICRORNA 378; MICRORNA 92A; UNCLASSIFIED DRUG; UNINDEXED DRUG;

3' UNTRANSLATED REGION; ADIPOGENESIS; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC HEPATITIS C; DIET INDUCED OBESITY; DNA POLYMORPHISM; DOWN REGULATION; ENZYME ACTIVITY; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLUCOSE HOMEOSTASIS; HEDGEHOG SIGNALING; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY POLYCYSTIC DISEASE; NEXT GENERATION SEQUENCING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTCH SIGNALING; OBESITY; OXIDATION; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; UPREGULATION; VIRUS LOAD; ANIMAL; DIET; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC MARKER; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; METABOLISM; MOLECULAR DIAGNOSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR;

ADIPOGENESIS; ANIMALS; DIET; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; GENETIC THERAPY; HUMANS; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 85034666323     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2017.10.015     Document Type: Review

References (248)

1. James, P.T., Leach, R., Kalamara, E., Shayeghi, M., The worldwide obesity epidemic. Obes Res 9:Suppl. 4 (2001), S228–S233.
2. Loos, R.J., Bouchard, C., FTO: the first gene contributing to common forms of human obesity. Obes Rev 9 (2008), 246–250.
3. Rojas, J., Arraiz, N., Aguirre, M., Velasco, M., Bermúdez, V., AMPK as target for intervention in childhood and adoleset cent obesity. J Obes, 2011, 2011, 252817.
4. Calle, E.E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004), 579–591.
5. Kopelman, P.G., Obesity as a medical problem. Nature 404 (2000), 635–643.
6. McGregor, R.A., Choi, M.S., MicroRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11 (2011), 304–316.
7. Gesta, S., Tseng, Y.H., Kahn, C.R., Developmental origin of fat: tracking obesity to its source. Cell 131 (2007), 242–256.
8. Arner, E., Westermark, P.O., Spalding, K.L., Britton, T., Rydén, M., Frisén, J., et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59 (2010), 105–109.
9. Cummings, D.E., Schwartz, M.W., Genetics and pathophysiology of human obesity. Annu Rev Med 54 (2003), 453–471.
10. de Ferranti, S., Mozaffarian, D., The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54 (2008), 945–955.
11. Heinonen, S., Saarinen, L., Naukkarinen, J., Rodríguez, A., Frühbeck, G., Hakkarainen, A., et al. Adipocyte morphology and implications for metabolic derangements in acquired obesity. Int J Obes (Lond) 38 (2014), 1423–1431.
12. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999), 143–147.
13. Moreno-Navarrete, J.M., Fernández-Real, J.M., Adipocyte differentiation. Symonds, M.E., (eds.) Adipose tissue biology, 2012, Springer, New York, 17–38.
14. Hamam, D., Ali, D., Kassem, M., Aldahmash, A., Alajez, N.M., MicroRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev 24 (2015), 417–425.
15. Rosen, E.D., MacDougald, O.A., Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7 (2006), 885–896.
16. Schaffer, J.E., Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14 (2003), 281–287.
17. Engin, A.B., MicroRNA and adipogenesis. Adv Exp Med Biol 960 (2017), 489–509.
18. Feve, B., Adipogenesis: cellular and molecular aspects. Best Pract Res Clin Endocrinol Metab 19 (2005), 483–499.
19. Gregoire, F.M., Smas, C.M., Sul, H.S., Understanding adipocyte differentiation. Physiol Rev 78 (1998), 783–809.
20. Cristancho, A.G., Lazar, M.A., Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12 (2011), 722–734.
21. Takada, I., Kouzmenko, A.P., Kato, S., Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5 (2009), 442–447.
22. Mota de Sá P., Richard, A.J., Hang, H., Stephens, J.M., Transcriptional regulation of adipogenesis. Compr Physiol 7 (2017), 635–674.
23. Amber-Vitos, O., Chaturvedi, N., Nachliel, E., Gutman, M., Tsfadia, Y., The effect of regulating molecules on the structure of the PPAR-RXR complex. Biochim Biophys Acta 2016 (1861), 1852–1863.
24. Thompson, G.M., Trainor, D., Biswas, C., LaCerte, C., Berger, J.P., Kelly, L.J., A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells. Anal Biochem 330 (2004), 21–28.
25. Arimura, N., Horiba, T., Imagawa, M., Shimizu, M., Sato, R., The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J Biol Chem 279 (2004), 10070–10076.
26. Kim, Y.J., Cho, S.Y., Yun, C.H., Moon, Y.S., Lee, T.R., Kim, S.H., Transcriptional activation of Cidec by PPARgamma2 in adipocyte. Biochem Biophys Res Commun 377 (2008), 297–302.
27. Tang, Q.Q., Lane, M.D., Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 81 (2012), 715–736.
28. Moseti, D., Regassa, A., Kim, W.K., Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int J Mol Sci, 17(1), 2016, 10.3390/ijms17010124 pii: E124.
29. Blüher, M., Michael, M.D., Peroni, O.D., Ueki, K., Carter, N., Kahn, B.B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3 (2002), 25–38.
30. Smith, P.J., Wise, L.S., Berkowitz, R., Wan, C., Rubin, C.S., Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263 (1988), 9402–9408.
31. Casado-Díaz, A., Anter, J., Müller, S., Winter, P., Quesada-Gómez, J.M., Dorado, G., Transcriptomic analyses of adipocyte differentiation from human mesenchymal stromal-cells (MSC). J Cell Physiol 232 (2017), 771–784.
32. Ross, S.E., Hemati, N., Longo, K.A., Bennett, C.N., Lucas, P.C., Erickson, R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000), 950–953.
33. Liu, J., Farmer, S.R., Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 279 (2004), 45020–45027.
34. Laudes, M., Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol 46 (2011), R65–R72.
35. Shen, L., Glowacki, J., Zhou, S., Inhibition of adipocytogenesis by canonical WNT signaling in human mesenchymal stem cells. Exp Cell Res 317 (2011), 1796–1803.
36. Vujovic, S., Henderson, S.R., Flanagan, A.M., Clements, M.O., Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cells. Cell Prolif 40 (2007), 185–195.
37. Urs, S., Turner, B., Tang, Y., Rostama, B., Small, D., Liaw, L., Effect of soluble Jagged1-mediated inhibition of Notch signaling on proliferation and differentiation of an adipocyte progenitor cell model. Adipocyte 1:1 (2012), 46–57.
38. Shan, T., Liu, J., Wu, W., Xu, Z., Wang, Y., Roles of notch signaling in adipocyte progenitor cells and mature adipocytes. J Cell Physiol 232 (2017), 1258–1261.
39. Ugarte, F., Ryser, M., Thieme, S., Fierro, F.A., Navratiel, K., Bornhäuser, M., et al. Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37 (2009), 867–875.
40. Bi, P., Shan, T., Liu, W., Yue, F., Yang, X., Liang, X.R., et al. Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med 20:8 (2014), 911–918.
41. Bi, P., Yue, F., Karki, A., Castro, B., Wirbisky, S.E., Wang, C., et al. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med 213 (2016), 2019–2037.
42. Gridley, T., Kajimura, S., Lightening up a notch: notch regulation of energy metabolism. Nat Med 20 (2014), 811–812.
43. Song, B.Q., Chi, Y., Li, X., Du, W.J., Han, Z.B., Tian, J.J., et al. Inhibition of Notch signaling promotes the adipogenic differentiation of mesenchymal stem cells through autophagy activation and PTEN-PI3K/AKT/mTOR pathway. Cell Physiol Biochem 36:5 (2015), 1991–2002.
44. Kaminska, B., Wesolowska, A., Danilkiewicz, M., TGF beta signalling and its role in tumour pathogenesis. Acta Biochim Pol 52 (2005), 329–337.
45. van Zoelen, E.J., Duarte, I., Hendriks, J.M., van der Woning, S.P., TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation. Stem Cell Res Ther, 7(1), 2016, 123, 10.1186/s13287-016-0375-3.
46. Clouthier, D.E., Comerford, S.A., Hammer, R.E., Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest 100:11 (1997), 2697–2713.
47. Choy, L., Derynck, R., Transforming growth factor-beta inhibits adipocyte differentiation by smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 278:11 (2003), 9609–9619.
48. Petruschke, T., Röhrig, K., Hauner, H., Transforming growth factor beta (TGF-beta) inhibits the differentiation of human adipocyte precursor cells in primary culture. Int J Obes Relat Metab Disord 18 (1994), 532–536.
49. Choy, L., Skillington, J., Derynck, R., Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol 149:3 (2000), 667–682.
50. McMahon, A.P., Ingham, P.W., Tabin, C.J., Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 53 (2003), 1–114.
51. Plaisant, M., Fontaine, C., Cousin, W., Rochet, N., Dani, C., Peraldi, P., Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Stem Cells 27:3 (2009), 703–713.
52. Fontaine, C., Cousin, W., Plaisant, M., Dani, C., Peraldi, P., Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem Cells 26:4 (2008), 1037–1046.
53. D'Alessio, A.C., Weaver, I.C., Szyf, M., Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes. Mol Cell Biol 27 (2007), 7462–7474.
54. Alexander, R., Lodish, H., Sun, L., MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets 15 (2011), 623–636.
55. Hilton, C., Neville, M.J., Karpe, F., MicroRNAs in adipose tissue: their role in adipogenesis and obesity. Int J Obes (Lond) 37 (2013), 325–332.
56. Wang, R., Hong, J., Cao, Y., Shi, J., Gu, W., Ning, G., et al. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults. Eur J Endocrinol 172 (2015), 291–300.
57. Mudhasani, R., Imbalzano, A.N., Jones, S.N., An essential role for Dicer in adipocyte differentiation. J Cell Biochem 110 (2010), 812–816.
58. Mudhasani, R., Puri, V., Hoover, K., Czech, M.P., Imbalzano, A.N., Jones, S.N., Dicer is required for the formation of white but not brown adipose tissue. J Cell Physiol 226 (2011), 1399–1406.
59. Brandão, B.B., Guerra, B.A., Mori, M.A., Shortcuts to a functional adipose tissue: the role of small non-coding RNAs. Redox Biol 12 (2017), 82–102.
60. Vienberg, S., Geiger, J., Madsen, S., Dalgaard, L.T., MicroRNAs in metabolism. Acta Physiol (Oxf) 219 (2017), 346–361.
61. Arner, P., Kulyté A., MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol 11 (2015), 276–288.
62. Deiuliis, J.A., MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond) 40 (2016), 88–101.
63. Shi, C., Huang, F., Gu, X., Zhang, M., Wen, J., Wang, X., et al. Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity. Oncotarget 7 (2016), 40830–40845.
64. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
65. Lee, R.C., Feinbaum, R.L., Ambros, V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993), 843–854.
66. Krol, J., Loedige, I., Filipowicz, W., The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11 (2010), 597–610.
67. Moore, A.C., Winkjer, J.S., Tseng, T.T., Bioinformatics resources for microRNA discovery. Biomark Insights 10 (2016), 53–58.
68. Ebert, M.S., Sharp, P.A., Roles for microRNAs in conferring robustness to biological processes. Cell 149 (2012), 515–524.
69. Matkovich, S.J., Van Booven, D.J., Eschenbacher, W.H., Dorn, G.W. 2nd, RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ Res 108 (2011), 18–26.
70. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
71. Ghildiyal, M., Zamore, P.D., Small silencing RNAs: an expanding universe. Nat Rev Genet 10 (2009), 94–108.
72. Ha, M., Kim, V.N., Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15 (2014), 509–554.
73. Mendell, J.T., Olson, E.N., MicroRNAs in stress signaling and human disease. Cell 148 (2012), 1172–1187.
74. Rottiers, V., Näär, A.M., MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13 (2012), 239–250.
75. Chen, L., Song, J., Cui, J., Hou, J., Zheng, X., Li, C., et al. MicroRNAs regulate adipocyte differentiation. Cell Biol Int 37 (2013), 533–546.
76. Kumarswamy, R., Volkmann, I., Thum, T., Regulation and function of miRNA-21 in health and disease. RNA Biol 8 (2011), 706–713.
77. Keller, P., Gburcik, V., Petrovic, N., Gallagher, I.J., Nedergaard, J., Cannon, B., et al. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord, 11, 2011, 7.
78. Kim, Y.J., Hwang, S.J., Bae, Y.C., Jung, J.S., MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27 (2009), 3093–3102.
79. Kim, Y.J., Hwang, S.H., Cho, H.H., Shin, K.K., Bae, Y.C., Jung, J.S., microRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. J Cell Physiol 227 (2012), 183–193.
80. Prusty, D., Park, B.H., Davis, K.E., Farmer, S.R., Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277 (2002), 46226–46232.
81. Mei, Y., Bian, C., Li, J., Du, Z., Zhou, H., Yang, Z., et al. miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem 114 (2013), 1374–1384.
82. Mendell, J.T., miRiad roles for the miR-17-92 cluster in development and disease. Cell 133 (2008), 217–222.
83. Wang, Q., Li, Y.C., Wang, J., Kong, J., Qi, Y., Quigg, R.J., et al. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci USA 105 (2008), 2889–2894.
84. Li, H., Li, T., Wang, S., Wei, J., Fan, J., Li, J., et al. miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 10 (2013), 313–324.
85. Zaragosi, L.E., Wdziekonski, B., Brigand, K.L., Villageois, P., Mari, B., Waldmann, R., et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol, 12, 2011, R64.
86. Wang, J., Guan, X., Guo, F., Zhou, J., Chang, A., Sun, B., et al. miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis, 4, 2013, e845.
87. Karbiener, M., Neuhold, C., Opriessnig, P., Prokesch, A., Bogner-Strauss, J.G., Scheideler, M., MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2. RNA Biol 8 (2011), 850–860.
88. Esau, C., Kang, X., Peralta, E., Hanson, E., Marcusson, E.G., Ravichandran, L.V., et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279 (2004), 52361–52365.
89. Romao, J.M., Jin, W., Dodson, M.V., Hausman, G.J., Moore, S.S., Guan, L.L., MicroRNA regulation in mammalian adipogenesis. Exp Biol Med (Maywood) 236 (2011), 997–1004.
90. Xie, H., Lim, B., Lodish, H.F., MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58 (2009), 1050–1057.
91. Kim, Y.J., Min, T.S., Seo, K.S., Kim, S.H., Expression of pref-1/dlk-1 is regulated by microRNA-143 in 3T3-L1 cells. Mol Biol Rep 42 (2015), 617–624.
92. Jordan, S.D., Krüger, M., Willmes, D.M., Redemann, N., Wunderlich, F.T., Brönneke, H.S., et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13 (2011), 434–446.
93. Sun, T., Fu, M., Bookout, A.L., Kliewer, S.A., Mangelsdorf, D.J., MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol 23 (2009), 925–931.
94. Parra, P., Serra, F., Palou, A., Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One, 5, 2010, e13005.
95. Gerin, I., Bommer, G.T., McCoin, C.S., Sousa, K.M., Krishnan, V., MacDougald, O.A., Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab 299 (2010), E198–E206.
96. Carrer, M., Liu, N., Grueter, C.E., Williams, A.H., Frisard, M.I., Hulver, M.W., et al. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci USA 109 (2012), 15330–15335.
97. Huang, N., Wang, J., Xie, W., Lyu, Q., Wu, J., He, J., et al. MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1. Biochem Biophys Res Commun 457 (2015), 37–42.
98. Yu, J., Kong, X., Liu, J., Lv, Y., Sheng, Y., Lv, S., et al. Expression profiling of PPARγ-regulated microRNAs in human subcutaneous and visceral adipogenesis in both genders. Endocrinology 155 (2014), 2155–2165.
99. Chen, K., He, H., Xie, Y., Zhao, L., Zhao, S., Wan, X., et al. miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis. Sci Rep, 5, 2015, 11909.
100. Ouyang, D., Ye, Y., Guo, D., Yu, X., Chen, J., Qi, J., MicroRNA-125b-5p inhibits proliferation and promotes adipogenic differentiation in 3T3-L1 preadipocytes. Acta Biochimica Biophysica Sinica (Shanghai) 47 (2015), 355–361.
101. Rockstroh, D., Löffler, D., Kiess, W., Landgraf, K., Körner, A., Regulation of human adipogenesis by miR125b-5p. Adipocyte 5 (2016), 283–297.
102. Roush, S., Slack, F.J., The let-7 family of microRNAs. Trends Cell Biol 18 (2008), 505–516.
103. Wei, J., Li, H., Wang, S., Li, T., Fan, J., Liang, X., et al. Let-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev 23 (2014), 1452–1463.
104. Anand, A., Chada, K., In vivo modulation of Hmgic reduces obesity. Nat Genet 24 (2000), 377–380.
105. Lin, Q., Gao, Z., Alarcon, R.M., Ye, J., Yun, Z., A role of miR-27 in the regulation of adipogenesis. FEBS J 276 (2009), 2348–2358.
106. Kim, S.Y., Kim, A.Y., Lee, H.W., Son, Y.H., Lee, G.Y., Lee, J.W., et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392 (2010), 323–328.
107. Karbiener, M., Fischer, C., Nowitsch, S., Opriessnig, P., Papak, C., Ailhaud, G., et al. MicroRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 390 (2009), 247–251.
108. Chen, S.Z., Xu, X., Ning, L.F., Jiang, W.Y., Xing, C., Tang, Q.Q., et al. miR-27 impairs the adipogenic lineage commitment via targeting lysyl oxidase. Obes (Silver Spring) 23 (2015), 2445–2453.
109. Roldan, M., Macias-Gonzalez, M., Garcia, R., Tinahones, F.J., Martin, M., Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J 25 (2011), 4111–4126.
110. Xie, W., Li, L., Zhang, M., Cheng, H.P., Gong, D., Lv, Y.C., et al. MicroRNA-27 prevents atherosclerosis by suppressing lipoprotein lipase-induced lipid accumulation and inflammatory response in apolipoprotein E knockout mice. PLoS One, 11, 2016, e0157085.
111. Mukherji, S., Ebert, M.S., Zheng, G.X., Tsang, J.S., Sharp, P.A., van Oudenaarden, A., MicroRNAs can generate thresholds in target gene expression. Nat Genet 43 (2011), 854–859.
112. Najafi-Shoushtari, S.H., Kristo, F., Li, Y., Shioda, T., Cohen, D.E., Gerszten, R.E., et al. microRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328 (2010), 1566–1569.
113. Price, N.L., Holtrup, B., Kwei, S.L., Wabitsch, M., Rodeheffer, M., Bianchini, L., et al. SREBP-1c/microRNA 33b genomic loci control adipocyte differentiation. Mol Cell Biol 36 (2016), 1180–1193.
114. Herrera, B.M., Lockstone, H.E., Taylor, J.M., Ria, M., Barrett, A., Collins, S., et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53 (2010), 1099–1109.
115. Chartoumpekis, D.V., Zaravinos, A., Ziros, P.G., Iskrenova, R.P., Psyrogiannis, A.I., Kyriazopoulou, V.E., et al. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One, 7, 2012, e34872.
116. Skarn, M., Namløs, H.M., Noordhuis, P., Wang, M.-Y., Meza-Zepeda, L.A., Myklebost, O., Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222. Stem Cells Dev 21 (2012), 873–883.
117. Ortega, F.J., Moreno-Navarrete, J.M., Pardo, G., Sabater, M., Hummel, M., Ferrer, A., et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One, 5, 2010, e9022.
118. Faraoni, I., Antonetti, F.R., Cardone, J., Bonmassar, E., miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792 (2009), 497–505.
119. Liu, S., Yang, Y., Wu, J., NFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem Biophys Res Commun 414 (2011), 618–624.
120. Loh, R.K.C., Kingwell, B.A., Carey, A.L., Human brown adipose tissue as a target for obesity management; beyond cold-induced thermogenesis. Obes Rev, 2017 Jul 14, 10.1111/obr.12584.
121. Shabalina, I.G., Petrovic, N., de Jong, J.M., Kalinovich, A.V., Cannon, B., Nedergaard, J., UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic. Cell Rep 5 (2013), 1196–1203.
122. Park, A., Kim, W.K., Bae, K.H., Distinction of white, beige and brown adipocytes derived from mesenchymal stem cells. World J Stem Cells 6 (2014), 33–42.
123. Harms, M., Seale, P., Brown and beige fat: development, function and therapeutic potential. Nat Med 19 (2013), 1252–1263.
124. van Marken Lichtenbelt, W.D., Vanhommerig, J.W., Smulders, N.M., Drossaerts, J.M., Kemerink, G.J., Bouvy, N.D., et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 360 (2009), 1500–1508.
125. Ouellet, V., Labbé S.M., Blondin, D.P., Phoenix, S., Guérin, B., Haman, F., et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 122 (2012), 545–552.
126. Chen, Y., Siegel, F., Kipschull, S., Haas, B., Fröhlich, H., Meister, G., et al. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun, 4, 2013, 1769, 10.1038/ncomms2742.
127. Trajkovski, M., Ahmed, K., Esau, C.C., Stoffel, M., MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol 14 (2012), 1330–1335.
128. Trajkovski, M., Lodish, H., MicroRNA networks regulate development of brown adipocytes. Trends Endocrinol Metab 24 (2013), 442–450.
129. Chen, Y., Pan, R., Pfeifer, A., Regulation of brown and beige fat by microRNAs. Pharmacol Ther 170 (2017), 1–7.
130. Karbiener, M., Scheideler, M., MicroRNA functions in brite/brown fat – novel perspectives towards anti-obesity strategies. Comput Struct Biotechnol J 11 (2014), 101–105.
131. Mori, M., Nakagami, H., Rodriguez-Araujo, G., Nimura, K., Kaneda, Y., Essential role for miR-196a in brown adipogenesis of white fat progenitor cells. PLoS Biol, 10, 2012, e1001314, 10.1371/journal.pbio.1001314.
132. Arias, N., Aguirre, L., Fernández-Quintela, A., González, M., Lasa, A., Miranda, J., et al. MicroRNAs involved in the browning process of adipocytes. J Physiol Biochem 72 (2016), 509–521.
133. Pan, D., Mao, C., Quattrochi, B., Friedline, R.H., Zhu, L.J., Jung, D.Y., et al. MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat Commun, 5, 2014, 4725, 10.1038/ncomms5725.
134. Karbiener, M., Pisani, D.F., Frontini, A., Oberreiter, L.M., Lang, E., Vegiopoulos, A., et al. MicroRNA-26 family is required for human adipogenesis and drives characteristics of brown adipocytes. Stem Cells 32 (2014), 1578–1590.
135. Fu, X., Dong, B., Tian, Y., Lefebvre, P., Meng, Z., Wang, X., et al. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. J Clin Invest 125 (2015), 2497–2509.
136. Hu, F., Wang, M., Xiao, T., Yin, B., He, L., Meng, W., et al. miR-30 promotes thermogenesis and the development of beige fat by targeting RIP140. Diabetes 64 (2015), 2056–2068.
137. Leonardsson, G., Steel, J.H., Christian, M., Pocock, V., Milligan, S., Bell, J., et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 101 (2004), 8437–8442.
138. Kim, J., Okla, M., Erickson, A., Carr, T., Natarajan, S.K., Chung, S., Eicosapentaenoic acid potentiates brown thermogenesis through FFAR4-dependent up-regulation of miR-30b and miR-378. J Biol Chem 291 (2016), 20551–20552.
139. Shin, D., Howng, S.Y., Ptáček, L.J., Fu, Y.H., miR-32 and its target SLC45A3 regulate the lipid metabolism of oligodendrocytes and myelin. Neuroscience 213 (2012), 29–37.
140. Ng, R., Hussain, N.A., Zhang, Q., Chang, C., Li, H., Fu, Y., et al. miRNA-32 drives brown fat thermogenesis and trans-activates subcutaneous white fat browning in mice. Cell Rep 19 (2017), 1229–1246.
141. Sun, L., Xie, H., Mori, M.A., Alexander, R., Yuan, B., Hattangadi, S.M., et al. Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 13 (2011), 958–965.
142. Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L.M., Uldry, M., et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab 6 (2007), 38–54.
143. Oliverio, M., Schmidt, E., Mauer, J., Baitzel, C., Hansmeier, N., Khani, S., et al. Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function. Nat Cell Biol 18 (2016), 328–336.
144. Meerson, A., Traurig, M., Ossowski, V., Fleming, J.M., Mullins, M., Baier, L.J., Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α. Diabetologia 56 (2013), 1971–1979.
145. Arner, E., Mejhert, N., Kulyté A., Balwierz, P.J., Pachkov, M., Cormont, M., et al. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61 (2012), 1986–1993.
146. Sun, L., Trajkovski, M., MiR-27 orchestrates the transcriptional regulation of brown adipogenesis. Metabolism 63 (2014), 272–282.
147. Kong, X., Yu, J., Bi, J., Qi, H., Di, W., Wu, L., et al. Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue. Diabetes 64 (2015), 393–404.
148. Fu, T., Choi, S.E., Kim, D.H., Seok, S., Suino-Powell, K.M., Xu, H.E., et al. Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho. Proc Natl Acad Sci U S A 109 (2012), 16137–16142.
149. Fu, T., Seok, S., Choi, S., Huang, Z., Suino-Powell, K., Xu, H.E., et al. microRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol 34 (2014), 4130–4142.
150. Kharitonenkov, A., Adams, A.C., Inventing new medicines: the FGF21 story. Mol Metab 3 (2013), 221–229.
151. Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26 (2012), 271–281.
152. Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 (2012), 463–468.
153. Ge, X., Sathiakumar, D., Lua, B.J., Kukreti, H., Lee, M., McFarlane, C., Myostatin signals through miR-34a to regulate Fndc5 expression and browning of white adipocytes. Int J Obes (Lond) 41 (2017), 137–148.
154. Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P.D., et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55 (2012), 183–193.
155. Chen, Y., Buyel, J.J., Hanssen, M.J., Siegel, F., Pan, R., Naumann, J., et al. Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun, 7, 2016, 11420, 10.1038/ncomms11420.
156. Liu, W., Bi, P., Shan, T., Yang, X., Yin, H., Wang, Y.X., et al. miR-133a regulates adipocyte browning in vivo. PLoS Genet, 9, 2013, e1003626, 10.1371/journal.pgen.1003626.
157. Liu, W., Kuang, S., miR-133 links to energy balance through targeting Prdm16. J Mol Cell Biol 5 (2013), 432–434.
158. Yin, H., Pasut, A., Soleimani, V.D., Bentzinger, C.F., Antoun, G., Thorn, S., et al. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab 17 (2013), 210–224.
159. Martinelli, R., Nardelli, C., Pilone, V., Buonomo, T., Liguori, R., Castanò I., et al. miR-519d Overexpression is associated with human obesity. Obesity 18 (2010), 2170–2176.
160. Heneghan, H.M., Miller, N., Kerin, M.J., Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11 (2010), 354–361.
161. Kristensen, M.M., Davidsen, P.K., Vigelsø A., Hansen, C.N., Jensen, L.J., Jessen, N., et al. miRNAs in human subcutaneous adipose tissue: effects of weight loss induced by hypocaloric diet and exercise. Obes (Silver Spring), 2017, 10.1002/oby.21765.
162. Xie, H., Sun, L., Lodish, H.F., Targeting microRNAs in obesity. Expert Opin Ther Targets 13 (2009), 1227–1238.
163. Coleman, C.B., Lightell, D.J. Jr., Moss, S.C., Bates, M., Parrino, P.E., Woods, T.C., Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin. Mol Cell Endocrinol 374 (2013), 125–129.
164. Shi, Z., Zhao, C., Guo, X., Ding, H., Cui, Y., Shen, R., et al. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERα expression in estrogen-induced insulin resistance. Endocrinology 155 (2014), 1982–1990.
165. Heneghan, H.M., Miller, N., McAnena, O.J., O'Brien, T., Kerin, M.J., Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 96 (2011), E846–E850.
166. Seeger, T., Fischer, A., Muhly-Reinholz, M., Zeiher, A.M., Dimmeler, S., Long-term inhibition of miR-21 leads to reduction of obesity in db/db mice. Obes (Silver Spring) 22 (2014), 2352–2360.
167. Kornfeld, J.W., Baitzel, C., Könner, A.C., Nicholls, H.T., Vogt, M.C., Herrmanns, K., et al. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 494 (2013), 111–115.
168. Mysore, R., Zhou, Y., Sädevirta, S., Savolainen-Peltonen, H., Nidhina Haridas, P.A., Soronen, J., et al. MicroRNA-192* impairs adipocyte triglyceride storage. Biochim Biophys Acta 2016 (1861), 342–351.
169. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105 (2008), 10513–10518.
170. Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Huang, K.H., Lee, M.J., et al. The microRNA spectrum in 12 body fluids. Clin Chem 56 (2010), 1733–1741.
171. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9 (2007), 654–659.
172. Thomou, T., Mori, M.A., Dreyfuss, J.M., Konishi, M., Sakaguchi, M., Wolfrum, C., et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature, 2017 Feb 15, 10.1038/nature21365.
173. Camussi, G., Deregibus, M.C., Bruno, S., Grange, C., Fonsato, V., Tetta, C., Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 1 (2011), 98–110.
174. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal, 2(100), 2009, ra81, 10.1126/scisignal.2000610.
175. Skog, J., Würdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10 (2008), 1470–1476.
176. Lässer, C., Alikhani, V.S., Ekström, K., Eldh, M., Paredes, P.T., Bossios, A., et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med, 9, 2011, 9, 10.1186/1479-5876-9-9.
177. Deng, Z.B., Poliakov, A., Hardy, R.W., Clements, R., Liu, C., Liu, Y., et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58 (2009), 2498–2505.
178. Ferrante, S.C., Nadler, E.P., Pillai, D.K., Hubal, M.J., Wang, Z., Wang, J.M., et al. Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease. Pediatr Res 77 (2015), 447–454.
179. Hubal, M.J., Nadler, E.P., Ferrante, S.C., Barberio, M.D., Suh, J.H., Wang, J., et al. Circulating adipocyte-derived exosomal microRNAs associated with decreased insulin resistance after gastric bypass. Obes (Silver Spring) 25 (2017), 102–110.
180. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., Ochiya, T., Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:23 (2010), 17442–17452.
181. Zhang, Y., Sun, X., Icli, B., Feinberg, M.W., Emerging roles for microRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev 38 (2017), 145–168.
182. Villard, A., Marchand, L., Thivolet, C., Rome, S., Diagnostic value of cell-free circulating microRNAs for obesity and type 2 diabetes: a meta-analysis. J Mol Biomark Diagn, 6(6), 2015 Nov pii: 251.
183. Fischer-Posovszky, P., Roos, J., Kotnik, P., Battelino, T., Inzaghi, E., Nobili, V., et al. Functional significance and predictive value of microRNAs in pediatric obesity: tiny molecules with huge impact?. Horm Res Paediatr 86 (2016), 3–10.
184. Ortega, F.J., Mercader, J.M., Catalán, V., Moreno-Navarrete, J.M., Pueyo, N., Sabater, M., et al. Targeting the circulating microRNA signature of obesity. Clin Chem 59 (2013), 781–792.
185. Carreras-Badosa, G., Bonmatí A., Ortega, F.J., Mercader, J.M., Guindo-Martínez, M., Torrents, D., et al. Altered circulating miRNA expression profile in pregestational and gestational obesity. J Clin Endocrinol Metab 100 (2015), E1446–E1456.
186. Wen, D., Qiao, P., Wang, L., Circulating microRNA-223 as a potential biomarker for obesity. Obes Res Clin Pract 9 (2015), 398–404.
187. Ortega, F.J., Mercader, J.M., Moreno-Navarrete, J.M., Rovira, O., Guerra, E., Esteve, E., et al. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care 37 (2014), 1375–1383.
188. Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D., Remaley, A.T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13 (2011), 423–433.
189. Iacomino, G., Russo, P., Stillitano, I., Lauria, F., Marena, P., Ahrens, W., et al. Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I.Family study. Genes Nutr, 11, 2016, 7.
190. Masotti, A., Baldassarre, A., Fabrizi, M., Olivero, G., Loreti, M.C., Giammaria, P., et al. Oral glucose tolerance test unravels circulating miRNAs associated with insulin resistance in obese preschoolers. Pediatr Obes, 2016, 10.1111/ijpo.12133.
191. Prats-Puig, A., Ortega, F.J., Mercader, J.M., Moreno-Navarrete, J.M., Moreno, M., Bonet, N., et al. Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab 98 (2013), E1655–E1660.
192. Can, U., Buyukinan, M., Yerlikaya, F.H., The investigation of circulating microRNAs associated with lipid metabolism in childhood obesity. Pediatr Obes 11 (2016), 228–234.
193. Kahn, B.B., Flier, J.S., Obesity and insulin resistance. J Clin Invest 106 (2000), 473–481.
194. Colagiuri, S., Diabesity: therapeutic options. Diabetes Obes Metab 12 (2010), 463–473.
195. Guilherme, A., Virbasius, J.V., Puri, V., Czech, M.P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9 (2008), 367–377.
196. Eckel, R.H., Kahn, S.E., Ferrannini, E., Goldfine, A.B., Nathan, D.M., Schwartz, M.W., et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized?. J Clin Endocrinol Metab 96 (2011), 1654–1663.
197. Bogardus, C., Missing heritability and GWAS utility. Obes (Silver Spring) 17 (2009), 209–210.
198. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007), 1341–1345.
199. Ono, K., MicroRNA links obesity and impaired glucose metabolism. Cell Res 21 (2011), 864–866.
200. Dehwah, M.A., Xu, A., Huang, Q., MicroRNAs and type 2 diabetes/obesity. J Genet Genomics 39 (2012), 11–18.
201. Williams, M.D., Mitchell, G.M., MicroRNAs in insulin resistance and obesity. Exp Diabetes Res, 2012, 2012, 484696, 10.1155/2012/484696.
202. Wu, L., Dai, X., Zhan, J., Zhang, Y., Zhang, H., Zhang, H., et al. Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus. APMIS 123 (2015), 580–585.
203. Karolina, D.S., Tavintharan, S., Armugam, A., Sepramaniam, S., Pek, S.L., Wong, M.T., et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 97 (2012), E2271–E2276.
204. Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474 (2011), 649–653.
205. Xu, Q., Shang, Y., Li, Y., Zhang, F., Gao, S., Yao, M., MicroRNAs 103 and 107 link type 2 diabetes and post-menopausal breast cancer. Int J of Diabetes Dev Ctries 36 (2016), 40–44.
206. Guglielmi, V., D'Adamo, M., Menghini, R., Cardellini, M., Gentileschi, P., Federici, M., et al. MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects. Nutr Healthy Aging 4 (2017), 141–145.
207. Dahlman, I., Belarbi, Y., Laurencikiene, J., Pettersson, A.M., Arner, P., Kulyté A., Comprehensive functional screening of miRNAs involved in fat cell insulin sensitivity among women. Am J Physiol Endocrinol Metab 312 (2017), E482–E494.
208. Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107 (2010), 810–817.
209. Ashoori, M.R., Rahmati-Yamchi, M., Ostadrahimi, A., Fekri Aval, S., Zarghami, N., MicroRNAs and adipocytokines: promising biomarkers for pharmacological targets in diabetes mellitus and its complications. Biomed Pharmacother 93 (2017), 1326–1336.
210. García-Segura, L., Pérez-Andrade, M., Miranda-Ríos, J., The emerging role of MicroRNAs in the regulation of gene expression by nutrients. J Nutr Nutr 6 (2013), 16–31.
211. Ross, S.A., Davis, C.D., The emerging role of microRNAs and nutrition in modulating health and disease. Annu Rev Nutr 34 (2014), 305–336.
212. Hernando Boigues, J.F., Mach, N., The effect of polyunsaturated fatty acids on obesity through epigenetic modifications. Endocrinol Nutr 62 (2015), 338–349.
213. Nolte-’t Hoen, E.N., Van Rooij, E., Bushell, M., Zhang, C.Y., Dashwood, R.H., James, W.P., et al. The role of microRNA in nutritional control. J Intern Med 278 (2015), 99–109.
214. He, A., Zhu, L., Gupta, N., Chang, Y., Fang, F., Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 21 (2007), 2785–2794.
215. Ling, H.Y., Ou, H.S., Feng, S.D., Zhang, X.Y., Tuo, Q.H., Chen, L.X., et al. Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol 36 (2009), e32–e39.
216. Takanabe, R., Ono, K., Abe, Y., Takaya, T., Horie, T., Wada, H., et al. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 376 (2008), 728–732.
217. Park, J.H., Ahn, J., Kim, S., Kwon, D.Y., Ha, T.Y., Murine hepatic miRNAs expression and regulation of gene expression in diet-induced obese mice. Mol Cells 31 (2011), 33–38.
218. Gallagher, I.J., Scheele, C., Keller, P., Nielsen, A.R., Remenyi, J., Fischer, C.P., et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med, 2, 2010, 9, 10.1186/gm130.
219. Milagro, F.I., Miranda, J., Portillo, M.P., Fernandez-Quintela, A., Campión, J., Martínez, J.A., High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS One, 8, 2013, e54319.
220. Tabet, F., Cuesta Torres, L.F., Ong, K.L., Shrestha, S., Choteau, S.A., Barter, P.J., et al. High-Density lipoprotein-associated miR-223 is altered after diet-induced weight loss in overweight and obese males. PLoS One, 11, 2016, e0151061.
221. Richardson, K., Louie-Gao, Q., Arnett, D.K., Parnell, L.D., Lai, C.Q., Davalos, A., et al. The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site. PLoS One, 6, 2011, e17944.
222. Zhu, L., Shi, C., Ji, C., Xu, G., Chen, L., Yang, L., et al. FFAs and adipokine-mediated regulation of hsa-miR-143 expression in human adipocytes. Mol Biol Rep 40 (2013), 5669–5675.
223. Ortega, F.J., Cardona-Alvarado, M.I., Mercader, J.M., Moreno-Navarrete, J.M., Moreno, M., Sabater, M., et al. Circulating profiling reveals the effect of a polyunsaturated fatty acid-enriched diet on common microRNAs. J Nutr Biochem 26 (2015), 1095–1101.
224. Zhang, L., Hou, D., Chen, X., Li, D., Zhu, L., Zhang, Y., et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22 (2012), 107–126 Erratum in: Cell Res 2012; 22: 273–4.
225. Kosaka, N., Izumi, H., Sekine, K., Ochiya, T., microRNA as a new immune-regulatory agent in breast milk. Silence, 1, 2010, 7, 10.1186/1758-907X-1-7.
226. Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
227. Janssen, H.L., Kauppinen, S., Hodges, M.R., HCV infection and miravirsen. N Engl J Med 369 (2013), 877–878.
228. Eulalio, A., Mano, M., Dal Ferro, M., Zentilin, L., Sinagra, G., Zacchigna, S., et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492 (2012), 376–381.
229. Obad, S., dos Santos, C.O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43 (2011), 371–378.
230. Lanford, R.E., Hildebrandt-Eriksen, E.S., Petri, A., Persson, R., Lindow, M., Munk, M.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327 (2010), 198–201.
231. Marquart, T.J., Allen, R.M., Ory, D.S., Baldán, A., miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 107 (2010), 12228–12232.
232. Rayner, K.J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M.L., Tamehiro, N., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328 (2010), 1570–1573.
233. Horie, T., Ono, K., Horiguchi, M., Nishi, H., Nakamura, T., Nagao, K., et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A 107 (2010), 17321–17326.
234. Rayner, K.J., Esau, C.C., Hussain, F.N., McDaniel, A.L., Marshall, S.M., van Gils, J.M., et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478 (2011), 404–407.
235. Hajarnis, S., Lakhia, R., Yheskel, M., Williams, D., Sorourian, M., Liu, X., et al. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism. Nat Commun, 8, 2017, 14395, 10.1038/ncomms14395.
236. Klöting, N., Berthold, S., Kovacs, P., Schön, M.R., Fasshauer, M., Ruschke, K., et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One, 4, 2009, e4699, 10.1371/journal.pone.0004699.
237. Diawara, M.R., Hue, C., Wilder, S.P., Venteclef, N., Aron-Wisnewsky, J., Scott, J., et al. Adaptive expression of microRNA-125a in adipose tissue in response to obesity in mice and men. PLoS One, 9, 2014, e91375, 10.1371/journal.pone.0091375.
238. Chou, W.W., Wang, Y.T., Liao, Y.C., Chuang, S.C., Wang, S.N., Juo, S.H., Decreased microRNA-221 is associated with high levels of TNF-α in human adipose tissue-derived mesenchymal stem cells from obese woman. Cell Physiol Biochem 32 (2013), 127–137.
239. Capobianco, V., Nardelli, C., Ferrigno, M., Iaffaldano, L., Pilone, V., Forestieri, P., et al. miRNA and protein expression profiles of visceral adipose tissue reveal miR-141/YWHAG and miR-520e/RAB11A as two potential miRNA/protein target pairs associated with severe obesity. Proteome Res 11 (2012), 3358–3369.
240. Pang, L., You, L., Ji, C., Shi, C., Chen, L., Yang, L., et al. miR-1275 inhibits adipogenesis via ELK1 and its expression decreases in obese subjects. J Mol Endocrinol 57 (2016), 33–43.
241. Pek, S.L., Sum, C.F., Lin, M.X., Cheng, A.K., Wong, M.T., Lim, S.C., et al. Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and Type 2 diabetes. Mol Cell Endocrinol 427 (2016), 112–123.
242. Wang, Y.C., Li, Y., Wang, X.Y., Zhang, D., Zhang, H., Wu, Q., et al. Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity. Diabetologia 56 (2013), 2275–2285.
243. Thomé J.G., Mendoza, M.R., Cheuiche, A.V., La Porta, V.L., Silvello, D., Dos Santos, K.G., et al. Circulating microRNAs in obese and lean heart failure patients: a case-control study with computational target prediction analysis. Gene 574 (2015), 1–10.
244. Khalyfa, A., Kheirandish-Gozal, L., Khalyfa, A.A., Philby, M.F., Alonso-Álvarez, M.L., Mohammadi, M., et al. Circulating plasma extracellular microvesicle microRNA cargo and endothelial dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med 194 (2016), 1116–1126.
245. Mazloom, H., Alizadeh, S., Esfahani, E.N., Razi, F., Meshkani, R., Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects. Mol Cell Biochem 419 (2016), 11–17.
246. Murri, M., Insenser, M., Fernández-Durán, E., San-Millán, J.L., Escobar-Morreale, H.F., Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. J Clin Endocrinol Metab 98 (2013), E1835–E1844.
247. Koh, E.H., Chen, Y., Bader, D.A., Hamilton, M.P., He, B., York, B., et al. Mitochondrial activity in human white adipocytes is regulated by the ubiquitin carrier protein 9/microRNA-30a Axis. J Biol Chem 291 (2016), 24747–24755.
248. Chou, C.F., Lin, Y.Y., Wang, H.K., Zhu, X., Giovarelli, M., Briata, P., et al. KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression. Diabetes 63 (2014), 2949–2961.